Disc Medicine, Inc.
Tremor tracks 2 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
- IRONDisc Medicine, Inc0Calm
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Running, no new patientsPhase 260 patientsMain results: Jul 2027 - IRONDisc Medicine, Inc0Calm
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Signing up patientsPhase 1/2150 patientsMain results: May 2027
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
48 sales (1 not pre-planned) · 0 purchases
- Bitterman KevinBoard member · Oct 21, 2026Sold 13,783 sharesabout $1.1 million · pre-planned
- Bitterman KevinBoard member · Oct 21, 2026Sold 11,470 sharesabout $920 thousand · pre-planned
- Bitterman KevinBoard member · Oct 21, 2026Sold 266 sharesabout $21 thousand · pre-planned
- Bitterman KevinBoard member · Oct 20, 2026Sold 2,869 sharesabout $229 thousand · pre-planned
- Bitterman KevinBoard member · Oct 20, 2026Sold 2,388 sharesabout $191 thousand · pre-planned
- Bitterman KevinBoard member · Oct 20, 2026
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- New shares being soldNew shares being sold (424B5)Nov 5, 2026
- Quarterly reportQuarterly report (10-Q)Nov 5, 2026
- Shared quarterly resultsNews report (8-K)Nov 5, 2026
- Signed a major agreement; Shared quarterly results; Other newsNews report (8-K)Oct 22, 2026
- New shares being soldNew shares being sold (424B5)Oct 21, 2026
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.